Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy

NCT00666263 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Multifocal Motor Neuropathy

Interventions

BIOLOGICAL: Immune Globulin Intravenous (human), 10%
BIOLOGICAL: 0.25% human albumin solution (Placebo)

Sponsor

Baxalta now part of Shire